CBP and p27KIP1 in Prostate Carcinogenesis
Abstract
CBP and p27KIP1 are two genes that are highly relevant to human prostate cancer. The objective of this proposal is to test the hypothesis that deletion of both alleles of CBP, in conjunction with deletion of one allele of p27KIP1, will result in the development of high-grade tumor in the prostate. The specific aims are to create CBP/p27KIP1 double knockout mice, to determine whether they present enhanced tumor progression compared to CBP single knockout mice alone, and to determine whether the application of two drugs, bortezomib and suberoylanilide hydroxamic acid (SAHA), are effective for the treatment of prostate tumors developed in CBP/p27KIP1 mice. As scheduled in our proposal, we have generated CBP/p27KIP1 compound knockout mice in the past funding year. Moreover, more than 120 additional mice, including CBP/p27KIP1 double knockout male mice and their control littermates, are currently maintained in our laboratory in order to monitor tumor formation and progression.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2008
- Accession Number
- ADA482779
Entities
People
- Haojie Hunag
Organizations
- University of Minnesota